Last Posted: Dec 03, 2020
- TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge.
Grill Sabine et al. Archives of gynecology and obstetrics 2020 Nov
- The role of TP53 pathogenic variants in early-onset HER2-positive breast cancer.
Escudeiro Carla et al. Familial cancer 2020 Oct
- Radiation therapy and secondary malignancy in Li-Fraumeni syndrome: A hereditary cancer registry study.
Hendrickson Peter G et al. Cancer medicine 2020 Sep
- Retrospective investigation of hereditary syndromes in patients with medulloblastoma in a single institution.
Wang Ying et al. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2020 Sep
- Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes.
Pietragalla Antonella et al. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2020 Sep
- Penetrance Estimates Over Time to First and Second Primary Cancer Diagnosis in Families with Li-Fraumeni Syndrome: A Single Institution Perspective.
Shin Seung Jun et al. Cancer research 2020 80(2) 347-353
- Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter Cohorts.
Shin Seung Jun et al. Cancer research 2020 80(2) 354-360
- [Challenges of screening germline predispositions in children].
Manabe Atsushi et al. [Rinsho ketsueki] The Japanese journal of clinical hematology 2020 61(6) 682-686
- "I need to know if I'm going to die young": Adolescent and young adult experiences of genetic testing for Li-Fraumeni syndrome.
Forbes Shepherd Rowan et al. Journal of psychosocial oncology 2020 May 1-20
- Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
T Frebourg et al, EJHG et al, May 26, 2020
- The Brazilian TP53 mutation (R337H) and sarcomas.
Volc Sahlua Miguel et al. PloS one 2020 15(1) e0227260
- Couples coping with screening burden and diagnostic uncertainty in Li-Fraumeni syndrome: Connection versus independence.
Young Jennifer L et al. Journal of psychosocial oncology 37(2) 178-193
- TP53 variants of uncertain significance: increasing challenges in variant interpretation and genetic counseling.
Bittar Camila Matzenbacher et al. Familial cancer 2019 18(4) 451-456
- Health professionals' practice for young people with, or at risk of, Li-Fraumeni syndrome: An Australasian survey.
Forbes Shepherd Rowan et al. Journal of genetic counseling 2019 Dec
- Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION SUMMARY, Number 793.
et al. Obstetrics and gynecology 2019 Dec 134(6) 1366-1367
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic discoveries into improved health outcomes related to rare diseases...more
- NIH Information (2)
- Human Genome Epidemiologic Studies (75)
- GWAS Studies (1)
- Human Genomics Translation/Implementation Studies (51)
- Genomic Tests Evidence Synthesis (6)
- Genomic Tests Guidelines (8)
- State Public Health Genomics Programs (1)
- Reviews/Commentaries (20)
- Tools/Methods (1)
- Ethical/Legal and Social Issues (ELSI) (1)
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.